Shaping better health
REMEDY : BNSSG referral pathways & Joint Formulary

BNSSG Paediatric Joint Formulary
Home > Formulary : Paediatric > Recent Decisions > 2021 >

Decisions 8th June 2021

At the meeting on the 8th June the following decisions were agreed


New Drug Requests


VeraSeal® (TLS Red)

  • for improvement of haemostatis in paediatric surgery

Budesonide/formoterol (Symbicort 100/3 pMDI) (TLS Green)

  • the pMDI formulation has been approved as an option for moderate to severe asthma

Shared Care Protocols/TLS changes

New SCPs:

Phenobarbital (new SCP, previously Phenobarbital was awaiting a SCP)

Levetiracetam (new SCP, previously Levetiractam was awaiting a SCP)

Brivaracetam (new SCP following approval of TLS Change from TLS Red to TLS Amber SCP)

Updated SCPs:


TLS Changes:

Brivaracetam TLS Red to TLS Amber SCP

Other Formulary Decisions:

  • The introductory pages to the Joint Formulary will be updated for both Adults and Paeds to provide further clarity